nach oben

Endocrine

Erschienen in:

01.12.2014 | Review

New vistas in the diagnosis of diabetic polyneuropathy

verfasst von: Nikolaos Papanas, Dan Ziegler

Erschienen in: Endocrine | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

New modalities are now available to improve the diagnosis of diabetic polyneuropathy (DPN). The present review discusses the progress achieved in this area. First, the minimal diagnostic criteria have been better clarified. Moreover, there are now new bedside tests available, such as the indicator test Neuropad, NeuroQuick, Ipswich Touch Test (IpTT), Vibratip, NC-stat^®/DPNCheck™ for automated nerve conduction study (NCS), tactile circumferential discriminator, steel ball-bearing, and SUDOSCAN^®, while more sophisticated modalities include skin biopsy and corneal confocal microscopy (CCM). Some tests can be used as screening tools, including primary care setting (Neuropad, IpTT, Vibratip, automated NCS), while others are more suitable for research, including evaluation of DPN in prospective studies (CCM, skin biopsy). Importantly, there is some evidence of earlier DPN diagnosis with the aid of some tests (Neuropad, skin biopsy, CCM). Further advantages provided by different tests are educational value and self-examination. Thus far, the potential of these tests has not been fully utilised. In particular, they have not been validated against standardised clinical examination scores in terms of predicting foot ulcers and amputations. Hence, it now remains to investigate the potential benefits from the widespread use of these tests for earlier and easier diagnosis of DPN in the everyday clinic.

A.J. Boulton, A.I. Vinik, J.C. Arezzo, V. Bril, E.L. Feldman, R. Freeman, R.A. Malik, R.E. Maser, J.M. Sosenko, D. Ziegler, American Diabetes Association. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 28, 956–962 (2005)PubMedCrossRef

S. Tesfaye, A.J. Boulton, P.J. Dyck, R. Freeman, M. Horowitz, P. Kempler, G. Lauria, R.A. Malik, V. Spallone, A. Vinik, L. Bernardi, P. Valensi, Toronto Diabetic Neuropathy Expert Group. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 33, 2285–2293 (2010)PubMedCentralPubMedCrossRef

A.L. Carrington, J.E. Shaw, C.H. Van Schie, C.A. Abbott, L. Vileikyte, A.J. Boulton, Can motor nerve conduction velocity predict foot problems in diabetic subjects over a 6-year outcome period? Diabetes Care 25, 2010–2015 (2002)PubMedCrossRef

N. Papanas, E. Maltezos, The diabetic foot: established and emerging treatments. Acta Clin. Belg. 62, 230–238 (2007)PubMedCrossRef

A.J. Boulton, The diabetic foot: grand overview, epidemiology and pathogenesis. Diabetes Metab. Res. Rev. 24(Suppl 1), S3–S6 (2008)PubMedCrossRef

N. Papanas, E. Maltezos, M. Edmonds, Salvation of the diabetic foot: still a quest for the Holy Grail? Vasa 40, 267–269 (2011)PubMedCrossRef

A.J. Boulton, R.S. Kirsner, L. Vileikyte, Clinical practice. Neuropathic diabetic foot ulcers. N. Engl. J. Med. 351, 48–55 (2004)PubMedCrossRef

J. Apelqvist, Diagnostics and treatment of the diabetic foot. Endocrine 41, 384–397 (2012)PubMedCrossRef

N.K. Chammas, R.L. Hill, A.V. Foster, M.E. Edmonds, Is neuropathic ulceration the key to understanding increased mortality due to ischaemic heart disease in diabetic foot ulcer patients? A population approach using a proportionate model. J. Int. Med. Res. 30, 553–559 (2002)PubMedCrossRef

10.

J. van Baal, R. Hubbard, F. Game, W. Jeffcoate, Mortality associated with acute Charcot foot and neuropathic foot ulceration. Diabetes Care 33, 1086–1089 (2010)PubMedCentralPubMedCrossRef

11.

N. Papanas, A.I. Vinik, D. Ziegler, Neuropathy in prediabetes: does the clock start ticking early? Nat. Rev. Endocrinol. 7, 682–690 (2011)PubMedCrossRef

12.

N. Papanas, D. Ziegler, Polyneuropathy in impaired glucose tolerance: is postprandial hyperglycemia the main culprit? A mini-review. Gerontology 59, 193–198 (2013)PubMedCrossRef

13.

N. Papanas, D. Ziegler, New diagnostic tests for diabetic distal symmetric polyneuropathy. J. Diabetes Complic. 25, 44–51 (2011)CrossRef

14.

N. Papanas, A.J. Boulton, R.A. Malik, C. Manes, O. Schnell, V. Spallone, N. Tentolouris, S. Tesfaye, P. Valensi, D. Ziegler, P. Kempler, A simple new non-invasive sweat indicator test for the diagnosis of diabetic neuropathy. Diabet. Med. 30, 525–534 (2013)PubMedCrossRef

15.

D. Ziegler, E. Siekierka-Kleiser, B. Meyer, M. Schweers, Validation of a novel screening device (NeuroQuick) for quantitative assessment of small nerve fiber dysfunction as an early feature of diabetic polyneuropathy. Diabetes Care 28, 1169–1174 (2005)PubMedCrossRef

16.

G. Rayman, P.R. Vas, N. Baker, C.G. Taylor Jr, C. Gooday, A.I. Alder, M. Donohoe, The Ipswich Touch Test: a simple and novel method to identify inpatients with diabetes at risk of foot ulceration. Diabetes Care 34, 1517–1518 (2011)PubMedCentralPubMedCrossRef

17.

F.L. Bowling, C.A. Abbott, W.E. Harris, S. Atanasov, R.A. Malik, A.J. Boulton, A pocket-sized disposable device for testing the integrity of sensation in the outpatient setting. Diabet. Med. 29, 1550–1552 (2012)PubMedCrossRef

18.

N. Bracewell, F. Game, W. Jeffcoate, B.E. Scammell, Clinical evaluation of a new device in the assessment of peripheral sensory neuropathy in diabetes. Diabet. Med. 29, 1553–1555 (2012)PubMedCrossRef

19.

A.I. Vinik, X. Kong, J.T. Megerian, S.N. Gozani, Diabetic nerve conduction abnormalities in the primary care setting. Diabetes Technol. Ther. 8, 654–662 (2006)PubMedCrossRef

20.

L. Vileikyte, G. Hutchings, S. Hollis, A.J. Boulton, The tactile circumferential discriminator. A new, simple screening device to identify diabetic patients at risk of foot ulceration. Diabetes Care 20, 623–626 (1997)PubMedCrossRef

21.

N. Papanas, A. Gries, E. Maltezos, R. Zick, The steel ball-bearing test: a new test for evaluating protective sensation in the diabetic foot. Diabetologia 49, 739–743 (2006)PubMedCrossRef

22.

J.H. Calvet, J. Dupin, H. Winiecki, P.E. Schwarz, Assessment of small fiber neuropathy through a quick, simple and non invasive method in a German diabetes outpatient clinic. Exp. Clin. Endocrinol. Diabetes 121, 80–83 (2013)PubMed

23.

G. Lauria, M. Bakkers, C. Schmitz, R. Lombardi, P. Penza, G. Devigili, A.G. Smith, S.T. Hsieh, S.I. Mellgren, T. Umapathi, D. Ziegler, C.G. Faber, I.S. Merkies, Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study. J. Peripher. Nerv. Syst. 15, 202–207 (2010)PubMedCrossRef

24.

N. Papanas, D. Ziegler, Corneal confocal microscopy: a new technique for early detection of diabetic neuropathy. Curr. Diab. Rep. 13, 488–499 (2013)PubMedCrossRef

25.

N. Papanas, K. Papatheodorou, D. Christakidis, D. Papazoglou, G. Giassakis, H. Piperidou, C. Monastiriotis, E. Maltezos, Evaluation of a new indicator test for sudomotor function (Neuropad^®) in the diagnosis of peripheral neuropathy in type 2 diabetic patients. Exp. Clin. Endocrinol. Diabetes 113, 195–198 (2005)PubMedCrossRef

26.

N. Papanas, K. Papatheodorou, D. Papazoglou, D. Christakidis, C. Monastiriotis, E. Maltezos, The new indicator test (Neuropad): a valuable diagnostic tool for small-fiber impairment in patients with type 2 diabetes. Diabetes Educ. 33, 257–266 (2007)PubMedCrossRef

27.

V. Spallone, R. Morganti, M. Siampli, T. Fedele, C. D’Amato, L. Cacciotti, M.R. Maiello, Neuropad as a diagnostic tool for diabetic autonomic and sensorimotor neuropathy. Diabet. Med. 26, 686–692 (2009)PubMedCrossRef

28.

N. Papanas, P. Paschos, D. Papazoglou, K. Papatheodorou, K. Paletas, E. Maltezos, A. Tsapas, Accuracy of the Neuropad test for the diagnosis of distal symmetric polyneuropathy in type 2 diabetes. Diabetes Care 34, 1378–1382 (2011)PubMedCentralPubMedCrossRef

29.

N. Papanas, G. Giassakis, K. Papatheodorou, D. Papazoglou, C. Monastiriotis, D. Christakidis, H. Piperidou, E. Maltezos, Use of the new indicator test (Neuropad) for the assessment of the staged severity of neuropathy in type 2 diabetic patients. Exp. Clin. Endocrinol. Diabetes 115, 58–61 (2007)PubMedCrossRef

30.

D. Ziegler, N. Papanas, M. Roden, for the GDC Study Group, Neuropad: evaluation of three cut-off points of sudomotor dysfunction for early detection of polyneuropathy in recently diagnosed diabetes. Diabet. Med. 28, 1412–1415 (2011)PubMedCrossRef

31.

C. Manes, N. Papanas, T. Exiara, N. Katsiki, S. Papantoniou, E. Kirlaki, S. Tsotoulidis, N. Kefalogiannis, E. Maltezos, The indicator test Neuropad in the assessment of small and overall nerve fibre dysfunction in patients with type 2 diabetes: a large multicentre study. Exp. Clin. Endocrinol. Diabetes 122, 195–199 (2014)PubMedCrossRef

32.

A. Tsapas, A. Liakos, P. Paschos, T. Karagiannis, E. Bekiari, N. Tentolouris, P. Boura, A simple plaster for screening for diabetic neuropathy: a diagnostic test accuracy systematic review and meta-analysis. Metabolism 63, 584–592 (2014)PubMedCrossRef

33.

N. Tentolouris, V. Achtsidis, K. Marinou, N. Katsilambros, Evaluation of the self-administered indicator plaster Neuropad for the diagnosis of neuropathy in diabetes. Diabetes Care 31, 236–237 (2008)PubMedCrossRef

34.

N. Papanas, K. Papatheodorou, D. Papazoglou, S. Kotsiou, E. Maltezos, A prospective study on the use of the indicator test Neuropad for the early diagnosis of peripheral neuropathy in type 2 diabetes. Exp. Clin. Endocrinol. Diabetes 119, 122–125 (2011)PubMedCrossRef

35.

N. Papanas, K. Papatheodorou, D. Papazoglou, D. Christakidis, C. Monastiriotis, E. Maltezos, Reproducibility of the new indicator test for sudomotor function (Neuropad) in patients with type 2 diabetes mellitus: short communication. Exp. Clin. Endocrinol. Diabetes 113, 577–581 (2005)PubMedCrossRef

36.

D. Ziegler, N. Papanas, W. Rathmann, M. Heier, M. Scheer, C. Meisinger, KORA Study Group. Evaluation of the Neuropad sudomotor function test as a screening tool for polyneuropathy in the elderly population with diabetes and pre-diabetes: the KORA F4 survey. Diabetes Metab. Res. Rev. 28, 692–697 (2012)PubMedCrossRef

37.

M.J. Young, A.J. Boulton, A.F. MacLeod, D.R. Williams, P.H. Sonksen, A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 36, 150–154 (1993)PubMedCrossRef

38.

B.A. Perkins, J. Grewal, E. Ng, M. Ngo, V. Bril, Validation of a novel point-of-care nerve conduction device for the detection of diabetic sensorimotor polyneuropathy. Diabetes Care 29, 2023–2027 (2006)PubMedCrossRef

39.

A.I. Vinik, M.S. Emley, J.T. Megerian, S.N. Gozani, Median and ulnar nerve conduction measurements in patients with symptoms of diabetic peripheral neuropathy using the NC-stat system. Diabetes Technol. Ther. 6, 816–824 (2004)PubMedCrossRef

40.

X. Kong, S.N. Gozani, M.T. Hayes, D.H. Weinberg, NC-stat sensory nerve conduction studies in the median and ulnar nerves of symptomatic patients. Clin. Neurophysiol. 117, 405–413 (2006)PubMedCrossRef

41.

X. Kong, E.A. Lesser, J.T. Megerian, S.N. Gozani, Repeatability of nerve conduction measurements using automation. J. Clin. Monit. Comput. 20, 405–410 (2006)PubMedCentralPubMedCrossRef

42.

B. Boettcher, B. Tracey, X. Kong, M. Williams, S.N. Gozani, A rapid, low-cost, point-of-care test for diabetic peripheral neuropathy. Diabetes 60, 637 (2011)

43.

X. Kong, B. Boettcher, K. Snow, S. Gozani, Reproducibility of a rapid point-of-care sural nerve conduction test. Diabetes 61, 595 (2012)

44.

A.I. Vinik, S.N. Gozani, Loss of sural responses estimated by a rapid and easily administered technique identifies greater neuropathy severity and risk in a general diabetes population. Diabetes 60, 650 (2011)

45.

J.A. Lee, E.M. Halpern, L.E. Lovblom, E. Yeung, V. Bril, B.A. Perkins, Reliability and validity of a point-of-care sural nerve conduction device for identification of diabetic neuropathy. PLoS ONE 9, e86515 (2014)PubMedCentralPubMedCrossRef

46.

R.E. Maser, C. Laudadio, M.J. Lenhard, G.S. DeCherney, A cross-sectional study comparing two quantitative sensory testing devices in individuals with diabetes. Diabetes Care 20, 179–181 (1997)PubMedCrossRef

47.

H. Gin, R. Baudoin, C.H. Raffaitin, V. Rigalleau, C. Gonzalez, Non-invasive and quantitative assessment of sudomotor function for peripheral diabetic neuropathy evaluation. Diabetes Metab. 37, 527–532 (2011)PubMedCrossRef

48.

C.M. Casellini, H.K. Parson, M.S. Richardson, M.L. Nevoret, A.I. Vinik, Sudoscan, a noninvasive tool for detecting diabetic small fiber neuropathy and autonomic dysfunction. Diabetes Technol. Ther. 15, 948–953 (2013)PubMedCentralPubMedCrossRef

49.

S. Løseth, E. Stålberg, R. Jorde, S.I. Mellgren, Early diabetic neuropathy: thermal thresholds and intraepidermal nerve fibre density in patients with normal nerve conduction studies. J. Neurol. 255, 1197–1202 (2008)PubMedCrossRef

50.

Joint Task Force of the EFNS and the PNS, European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. J. Peripher. Nerv. Syst. 15, 79–92 (2010)CrossRef

51.

M.I. Myers, A.C. Peltier, Uses of skin biopsy for sensory and autonomic nerve assessment. Curr. Neurol. Neurosci. Rep. 13, 323 (2013)PubMedCentralPubMedCrossRef

52.

C. Quattrini, M. Jeziorska, A.J. Boulton, R.A. Malik, Reduced vascular endothelial growth factor expression and intra-epidermal nerve fiber loss in human diabetic neuropathy. Diabetes Care 31, 140–145 (2008)PubMedCrossRef

53.

C. Quattrini, M. Tavakoli, M. Jeziorska, P. Kallinikos, S. Tesfaye, J. Finnigan, A. Marshall, A.J. Boulton, N. Efron, R.A. Malik, Surrogate markers of small fiber damage in human diabetic neuropathy. Diabetes 56, 2148–2154 (2007)PubMedCrossRef

54.

H. Narayanaswamy, P. Facer, V.P. Misra, M. Timmers, G. Byttebier, T. Meert, P. Anand, A longitudinal study of sensory biomarkers of progression in patients with diabetic peripheral neuropathy using skin biopsies. J. Clin. Neurosci. 19, 1490–1496 (2012)PubMedCrossRef

55.

M. Polydefkis, P. Hauer, S. Sheth, M. Sirdofsky, J.W. Griffin, J.C. McArthur, The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy. Brain 127, 1606–1615 (2004)PubMedCrossRef

56.

D. Ziegler, N. Papanas, A. Zhivov, S. Allgeier, K. Winter, I. Ziegler, J. Brüggemann, A. Strom, S. Peschel, B. Köhler, O. Stachs, R. F. Guthoff, M. Roden, for the GDS Group, Early detection of nerve fiber loss by corneal confocal microscopy and skin biopsy in recently diagnosed type 2 diabetes. Diabetes. doi:10.2337/db13-1819

57.

A. Strom, J. Brüggemann, I. Ziegler, K. Jeruschke, J. Weiss, H. Al-Hasani, M. Roden, D. Ziegler, for the GDS Group, Pronounced reduction of cutaneous Langerhans cell density in recently diagnosed type 2 diabetes. Diabetes 63, 1148–1153 (2014)PubMedCrossRef

58.

B. Köhler, S. Allgeier, F. Eberle, R. Guthoff, S. Maier, O. Stachs, A. Zhivov, D. Ziegler, G. Bretthauer, Image reconstruction of the corneal subbasal nerve plexus with extended field of view from focus image stacks of a confocal laser scanning microscope. Klin. Monbl. Augenheilkd. 228, 1060–1066 (2011)PubMedCrossRef

59.

E.A. Sellers, I. Clark, M. Tavakoli, H.J. Dean, J. McGavock, R.A. Malik, The acceptability and feasibility of corneal confocal microscopy to detect early diabetic neuropathy in children: a pilot study. Diabet. Med. 30, 630–631 (2013)PubMedCrossRef

60.

C. Quattrini, M. Tavakoli, P. Kallinikos et al., Comparing skin biopsy with corneal confocal microscopy: diagnostic yield of nerve fiber density. Diabetologia 53(Suppl 1), A1114 (2010)

61.

M. Tavakoli, C. Quattrini, P. Begum et al., Neuropad and corneal confocal microscopy: new indications for human diabetic neuropathy. Diabetologia 53(Suppl 1), A1112 (2010)

62.

F. Ishibashi, R. Kojima, A. Kawasaki, E. Yamanaka, A. Kosaka, H. Uetake, Correlation between sudomotor function, sweat gland duct size and corneal nerve fiber pathology in patients with type 2 diabetes mellitus. J. Diabetes Invest. (2013). doi:10.1111/jdi.12171

63.

M. Tavakoli, P. Kallinikos, A. Iqbal, A. Herbert, H. Fadavi, N. Efron, A.J. Boulton, R.A. Malik, Corneal confocal microscopy detects improvement in corneal nerve morphology with an improvement in risk factors for diabetic neuropathy. Diabet. Med. 28, 1261–1267 (2011)PubMedCentralPubMedCrossRef

64.

M. Tavakoli, M. Mitu-Pretorian, I.N. Petropoulos, H. Fadavi, O. Asghar, U. Alam, G. Ponirakis, M. Jeziorska, A. Marshall, N. Efron, A.J. Boulton, T. Augustine, R.A. Malik, Corneal confocal microscopy detects early nerve regeneration in diabetic neuropathy after simultaneous pancreas and kidney transplantation. Diabetes 62, 254–260 (2013)PubMedCentralPubMedCrossRef

65.

N. Efron, K. Edwards, N. Roper, N. Pritchard, G.P. Sampson, A.M. Shahidi, D. Vagenas, A. Russell, J. Graham, M.A. Dabbah, R.A. Malik, Repeatability of measuring corneal subbasal nerve fiber length in individuals with type 2 diabetes. Eye Contact Lens 36, 245–248 (2010)PubMedCrossRef

66.

P. Hertz, V. Bril, A. Orszag, A. Ahmed, E. Ng, P. Nwe, M. Ngo, P.A. Perkins, Reproducibility of in vivo corneal confocal microscopy as a novel screening test for early diabetic sensorimotor polyneuropathy. Diabet. Med. 28, 1253–1260 (2011)PubMedCrossRef

67.

I.N. Petropoulos, T. Manzoor, P. Morgan, H. Fadavi, O. Asghar, U. Alam, G. Ponirakis, M.A. Dabbah, X. Chen, J. Graham, M. Tavakoli, R.A. Malik, Repeatability of in vivo corneal confocal microscopy to quantify corneal nerve morphology. Cornea 32, e83–e89 (2013)PubMedCrossRef

68.

W.H. Herman, L. Kennedy, Underdiagnosis of peripheral neuropathy in type 2 diabetes. Diabetes Care 28, 1480–1841 (2005)PubMedCrossRef

69.

C. Gazzaruso, A. Coppola, T. Montalcini, E. Baffero, A. Garzaniti, G. Pelissero, S. Collaviti, A. Grugnetti, P. Gallotti, A. Pujia, S.B. Solerte, A. Giustina, Lipoprotein(a) and homocysteine as genetic risk factors for vascular and neuropathic diabetic foot in type 2 diabetes mellitus. Endocrine 41, 89–95 (2012)PubMedCrossRef

70.

American Diabetes Association, Standards of medical care in diabetes. Diabetes Care 36(Suppl 1), S11–S66 (2013)PubMedCentralCrossRef

71.

R. Sayın, M. Aslan, M. E. Kucukoglu, A. Luleci, M. Atmaca, R. Esen, H. Demir, Serum prolidase enzyme activity and oxidative stress levels in patients with diabetic neuropathy. Endocrine. doi:10.1007/s12020-013-0136-3

Titel: New vistas in the diagnosis of diabetic polyneuropathy
verfasst von: Nikolaos Papanas
Dan Ziegler
Publikationsdatum: 01.12.2014
Verlag: Springer US
Erschienen in: Endocrine / Ausgabe 3/2014
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-014-0285-z

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2014

Meta-analysis of the association of ADIPOQ G276T polymorphism with insulin resistance and blood glucose

The neuroprotective benefit from pioglitazone (PIO) addition on the alpha lipoic acid (ALA)-based treatment in experimental diabetic rats

Associations between fat distribution and volumetric bone mineral density in Chinese adults

Strict rules are needed for validation of G-protein-coupled receptor immunohistochemical studies in human tissues

The follicular outcome after standard gonadotropin stimulation is associated with ERα and ERβ genotypes